Global Drug Repositioning Market Research Report 2024(Status and Outlook)
Report Overview
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
This report provides a deep insight into the global Drug Repositioning market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning market in any manner.
Global Drug Repositioning Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market Segmentation (by Type)
Generic Drugs
Clinical Trial Failed Drugs
Market Segmentation (by Application)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
This report provides a deep insight into the global Drug Repositioning market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning market in any manner.
Global Drug Repositioning Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market Segmentation (by Type)
Generic Drugs
Clinical Trial Failed Drugs
Market Segmentation (by Application)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Repositioning Market
- Overview of the regional outlook of the Drug Repositioning Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Repositioning
1.2 Key Market Segments
1.2.1 Drug Repositioning Segment by Type
1.2.2 Drug Repositioning Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG REPOSITIONING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG REPOSITIONING MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Repositioning Revenue Market Share by Company (2019-2024)
3.2 Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Repositioning Market Size Sites, Area Served, Product Type
3.4 Drug Repositioning Market Competitive Situation and Trends
3.4.1 Drug Repositioning Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Repositioning Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING VALUE CHAIN ANALYSIS
4.1 Drug Repositioning Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG REPOSITIONING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG REPOSITIONING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Repositioning Market Size Market Share by Type (2019-2024)
6.3 Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
7 DRUG REPOSITIONING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Repositioning Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
8 DRUG REPOSITIONING MARKET SEGMENTATION BY REGION
8.1 Global Drug Repositioning Market Size by Region
8.1.1 Global Drug Repositioning Market Size by Region
8.1.2 Global Drug Repositioning Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Repositioning Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Repositioning Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Repositioning Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Repositioning Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Repositioning Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Drug Repositioning Basic Information
9.1.2 Teva Drug Repositioning Product Overview
9.1.3 Teva Drug Repositioning Product Market Performance
9.1.4 Teva Drug Repositioning SWOT Analysis
9.1.5 Teva Business Overview
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Drug Repositioning Basic Information
9.2.2 Novartis Drug Repositioning Product Overview
9.2.3 Novartis Drug Repositioning Product Market Performance
9.2.4 Novartis Drug Repositioning SWOT Analysis
9.2.5 Novartis Business Overview
9.2.6 Novartis Recent Developments
9.3 Mylan
9.3.1 Mylan Drug Repositioning Basic Information
9.3.2 Mylan Drug Repositioning Product Overview
9.3.3 Mylan Drug Repositioning Product Market Performance
9.3.4 Mylan Drug Repositioning SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Drug Repositioning Basic Information
9.4.2 Johnson and Johnson Drug Repositioning Product Overview
9.4.3 Johnson and Johnson Drug Repositioning Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Drug Repositioning Basic Information
9.5.2 Pfizer Drug Repositioning Product Overview
9.5.3 Pfizer Drug Repositioning Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Drug Repositioning Basic Information
9.6.2 Bausch Health Drug Repositioning Product Overview
9.6.3 Bausch Health Drug Repositioning Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 GSK
9.7.1 GSK Drug Repositioning Basic Information
9.7.2 GSK Drug Repositioning Product Overview
9.7.3 GSK Drug Repositioning Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 ChemRar Group
9.8.1 ChemRar Group Drug Repositioning Basic Information
9.8.2 ChemRar Group Drug Repositioning Product Overview
9.8.3 ChemRar Group Drug Repositioning Product Market Performance
9.8.4 ChemRar Group Business Overview
9.8.5 ChemRar Group Recent Developments
9.9 Glenmark
9.9.1 Glenmark Drug Repositioning Basic Information
9.9.2 Glenmark Drug Repositioning Product Overview
9.9.3 Glenmark Drug Repositioning Product Market Performance
9.9.4 Glenmark Business Overview
9.9.5 Glenmark Recent Developments
9.10 Fujifilm
9.10.1 Fujifilm Drug Repositioning Basic Information
9.10.2 Fujifilm Drug Repositioning Product Overview
9.10.3 Fujifilm Drug Repositioning Product Market Performance
9.10.4 Fujifilm Business Overview
9.10.5 Fujifilm Recent Developments
9.11 Dr. Reddy
9.11.1 Dr. Reddy Drug Repositioning Basic Information
9.11.2 Dr. Reddy Drug Repositioning Product Overview
9.11.3 Dr. Reddy Drug Repositioning Product Market Performance
9.11.4 Dr. Reddy Business Overview
9.11.5 Dr. Reddy Recent Developments
9.12 R-Pharma
9.12.1 R-Pharma Drug Repositioning Basic Information
9.12.2 R-Pharma Drug Repositioning Product Overview
9.12.3 R-Pharma Drug Repositioning Product Market Performance
9.12.4 R-Pharma Business Overview
9.12.5 R-Pharma Recent Developments
10 DRUG REPOSITIONING REGIONAL MARKET FORECAST
10.1 Global Drug Repositioning Market Size Forecast
10.2 Global Drug Repositioning Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Repositioning Market Size Forecast by Country
10.2.3 Asia Pacific Drug Repositioning Market Size Forecast by Region
10.2.4 South America Drug Repositioning Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Repositioning by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Repositioning Market Forecast by Type (2025-2030)
11.2 Global Drug Repositioning Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Repositioning
1.2 Key Market Segments
1.2.1 Drug Repositioning Segment by Type
1.2.2 Drug Repositioning Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG REPOSITIONING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG REPOSITIONING MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Repositioning Revenue Market Share by Company (2019-2024)
3.2 Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Repositioning Market Size Sites, Area Served, Product Type
3.4 Drug Repositioning Market Competitive Situation and Trends
3.4.1 Drug Repositioning Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Repositioning Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG REPOSITIONING VALUE CHAIN ANALYSIS
4.1 Drug Repositioning Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG REPOSITIONING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG REPOSITIONING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Repositioning Market Size Market Share by Type (2019-2024)
6.3 Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
7 DRUG REPOSITIONING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Repositioning Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
8 DRUG REPOSITIONING MARKET SEGMENTATION BY REGION
8.1 Global Drug Repositioning Market Size by Region
8.1.1 Global Drug Repositioning Market Size by Region
8.1.2 Global Drug Repositioning Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Repositioning Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Repositioning Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Repositioning Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Repositioning Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Repositioning Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Drug Repositioning Basic Information
9.1.2 Teva Drug Repositioning Product Overview
9.1.3 Teva Drug Repositioning Product Market Performance
9.1.4 Teva Drug Repositioning SWOT Analysis
9.1.5 Teva Business Overview
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Drug Repositioning Basic Information
9.2.2 Novartis Drug Repositioning Product Overview
9.2.3 Novartis Drug Repositioning Product Market Performance
9.2.4 Novartis Drug Repositioning SWOT Analysis
9.2.5 Novartis Business Overview
9.2.6 Novartis Recent Developments
9.3 Mylan
9.3.1 Mylan Drug Repositioning Basic Information
9.3.2 Mylan Drug Repositioning Product Overview
9.3.3 Mylan Drug Repositioning Product Market Performance
9.3.4 Mylan Drug Repositioning SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Drug Repositioning Basic Information
9.4.2 Johnson and Johnson Drug Repositioning Product Overview
9.4.3 Johnson and Johnson Drug Repositioning Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Drug Repositioning Basic Information
9.5.2 Pfizer Drug Repositioning Product Overview
9.5.3 Pfizer Drug Repositioning Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Drug Repositioning Basic Information
9.6.2 Bausch Health Drug Repositioning Product Overview
9.6.3 Bausch Health Drug Repositioning Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 GSK
9.7.1 GSK Drug Repositioning Basic Information
9.7.2 GSK Drug Repositioning Product Overview
9.7.3 GSK Drug Repositioning Product Market Performance
9.7.4 GSK Business Overview
9.7.5 GSK Recent Developments
9.8 ChemRar Group
9.8.1 ChemRar Group Drug Repositioning Basic Information
9.8.2 ChemRar Group Drug Repositioning Product Overview
9.8.3 ChemRar Group Drug Repositioning Product Market Performance
9.8.4 ChemRar Group Business Overview
9.8.5 ChemRar Group Recent Developments
9.9 Glenmark
9.9.1 Glenmark Drug Repositioning Basic Information
9.9.2 Glenmark Drug Repositioning Product Overview
9.9.3 Glenmark Drug Repositioning Product Market Performance
9.9.4 Glenmark Business Overview
9.9.5 Glenmark Recent Developments
9.10 Fujifilm
9.10.1 Fujifilm Drug Repositioning Basic Information
9.10.2 Fujifilm Drug Repositioning Product Overview
9.10.3 Fujifilm Drug Repositioning Product Market Performance
9.10.4 Fujifilm Business Overview
9.10.5 Fujifilm Recent Developments
9.11 Dr. Reddy
9.11.1 Dr. Reddy Drug Repositioning Basic Information
9.11.2 Dr. Reddy Drug Repositioning Product Overview
9.11.3 Dr. Reddy Drug Repositioning Product Market Performance
9.11.4 Dr. Reddy Business Overview
9.11.5 Dr. Reddy Recent Developments
9.12 R-Pharma
9.12.1 R-Pharma Drug Repositioning Basic Information
9.12.2 R-Pharma Drug Repositioning Product Overview
9.12.3 R-Pharma Drug Repositioning Product Market Performance
9.12.4 R-Pharma Business Overview
9.12.5 R-Pharma Recent Developments
10 DRUG REPOSITIONING REGIONAL MARKET FORECAST
10.1 Global Drug Repositioning Market Size Forecast
10.2 Global Drug Repositioning Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Repositioning Market Size Forecast by Country
10.2.3 Asia Pacific Drug Repositioning Market Size Forecast by Region
10.2.4 South America Drug Repositioning Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Repositioning by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Repositioning Market Forecast by Type (2025-2030)
11.2 Global Drug Repositioning Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Repositioning Market Size Comparison by Region (M USD)
Table 5. Global Drug Repositioning Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Repositioning Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2022)
Table 8. Company Drug Repositioning Market Size Sites and Area Served
Table 9. Company Drug Repositioning Product Type
Table 10. Global Drug Repositioning Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Repositioning
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Repositioning Market Challenges
Table 18. Global Drug Repositioning Market Size by Type (M USD)
Table 19. Global Drug Repositioning Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Repositioning Market Size Share by Type (2019-2024)
Table 21. Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Repositioning Market Size by Application
Table 23. Global Drug Repositioning Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Repositioning Market Share by Application (2019-2024)
Table 25. Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 33. Teva Drug Repositioning Basic Information
Table 34. Teva Drug Repositioning Product Overview
Table 35. Teva Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Teva Drug Repositioning SWOT Analysis
Table 37. Teva Business Overview
Table 38. Teva Recent Developments
Table 39. Novartis Drug Repositioning Basic Information
Table 40. Novartis Drug Repositioning Product Overview
Table 41. Novartis Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Novartis Drug Repositioning SWOT Analysis
Table 43. Novartis Business Overview
Table 44. Novartis Recent Developments
Table 45. Mylan Drug Repositioning Basic Information
Table 46. Mylan Drug Repositioning Product Overview
Table 47. Mylan Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Mylan Drug Repositioning SWOT Analysis
Table 49. Mylan Business Overview
Table 50. Mylan Recent Developments
Table 51. Johnson and Johnson Drug Repositioning Basic Information
Table 52. Johnson and Johnson Drug Repositioning Product Overview
Table 53. Johnson and Johnson Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Johnson and Johnson Business Overview
Table 55. Johnson and Johnson Recent Developments
Table 56. Pfizer Drug Repositioning Basic Information
Table 57. Pfizer Drug Repositioning Product Overview
Table 58. Pfizer Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Bausch Health Drug Repositioning Basic Information
Table 62. Bausch Health Drug Repositioning Product Overview
Table 63. Bausch Health Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Bausch Health Business Overview
Table 65. Bausch Health Recent Developments
Table 66. GSK Drug Repositioning Basic Information
Table 67. GSK Drug Repositioning Product Overview
Table 68. GSK Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 69. GSK Business Overview
Table 70. GSK Recent Developments
Table 71. ChemRar Group Drug Repositioning Basic Information
Table 72. ChemRar Group Drug Repositioning Product Overview
Table 73. ChemRar Group Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 74. ChemRar Group Business Overview
Table 75. ChemRar Group Recent Developments
Table 76. Glenmark Drug Repositioning Basic Information
Table 77. Glenmark Drug Repositioning Product Overview
Table 78. Glenmark Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Glenmark Business Overview
Table 80. Glenmark Recent Developments
Table 81. Fujifilm Drug Repositioning Basic Information
Table 82. Fujifilm Drug Repositioning Product Overview
Table 83. Fujifilm Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Fujifilm Business Overview
Table 85. Fujifilm Recent Developments
Table 86. Dr. Reddy Drug Repositioning Basic Information
Table 87. Dr. Reddy Drug Repositioning Product Overview
Table 88. Dr. Reddy Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Dr. Reddy Business Overview
Table 90. Dr. Reddy Recent Developments
Table 91. R-Pharma Drug Repositioning Basic Information
Table 92. R-Pharma Drug Repositioning Product Overview
Table 93. R-Pharma Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 94. R-Pharma Business Overview
Table 95. R-Pharma Recent Developments
Table 96. Global Drug Repositioning Market Size Forecast by Region (2025-2030) & (M USD)
Table 97. North America Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Europe Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 99. Asia Pacific Drug Repositioning Market Size Forecast by Region (2025-2030) & (M USD)
Table 100. South America Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Global Drug Repositioning Market Size Forecast by Type (2025-2030) & (M USD)
Table 103. Global Drug Repositioning Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Repositioning Market Size Comparison by Region (M USD)
Table 5. Global Drug Repositioning Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Repositioning Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2022)
Table 8. Company Drug Repositioning Market Size Sites and Area Served
Table 9. Company Drug Repositioning Product Type
Table 10. Global Drug Repositioning Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Repositioning
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Repositioning Market Challenges
Table 18. Global Drug Repositioning Market Size by Type (M USD)
Table 19. Global Drug Repositioning Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Repositioning Market Size Share by Type (2019-2024)
Table 21. Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Repositioning Market Size by Application
Table 23. Global Drug Repositioning Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Repositioning Market Share by Application (2019-2024)
Table 25. Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Repositioning Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Repositioning Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Repositioning Market Size by Region (2019-2024) & (M USD)
Table 33. Teva Drug Repositioning Basic Information
Table 34. Teva Drug Repositioning Product Overview
Table 35. Teva Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Teva Drug Repositioning SWOT Analysis
Table 37. Teva Business Overview
Table 38. Teva Recent Developments
Table 39. Novartis Drug Repositioning Basic Information
Table 40. Novartis Drug Repositioning Product Overview
Table 41. Novartis Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Novartis Drug Repositioning SWOT Analysis
Table 43. Novartis Business Overview
Table 44. Novartis Recent Developments
Table 45. Mylan Drug Repositioning Basic Information
Table 46. Mylan Drug Repositioning Product Overview
Table 47. Mylan Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Mylan Drug Repositioning SWOT Analysis
Table 49. Mylan Business Overview
Table 50. Mylan Recent Developments
Table 51. Johnson and Johnson Drug Repositioning Basic Information
Table 52. Johnson and Johnson Drug Repositioning Product Overview
Table 53. Johnson and Johnson Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Johnson and Johnson Business Overview
Table 55. Johnson and Johnson Recent Developments
Table 56. Pfizer Drug Repositioning Basic Information
Table 57. Pfizer Drug Repositioning Product Overview
Table 58. Pfizer Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Bausch Health Drug Repositioning Basic Information
Table 62. Bausch Health Drug Repositioning Product Overview
Table 63. Bausch Health Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Bausch Health Business Overview
Table 65. Bausch Health Recent Developments
Table 66. GSK Drug Repositioning Basic Information
Table 67. GSK Drug Repositioning Product Overview
Table 68. GSK Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 69. GSK Business Overview
Table 70. GSK Recent Developments
Table 71. ChemRar Group Drug Repositioning Basic Information
Table 72. ChemRar Group Drug Repositioning Product Overview
Table 73. ChemRar Group Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 74. ChemRar Group Business Overview
Table 75. ChemRar Group Recent Developments
Table 76. Glenmark Drug Repositioning Basic Information
Table 77. Glenmark Drug Repositioning Product Overview
Table 78. Glenmark Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Glenmark Business Overview
Table 80. Glenmark Recent Developments
Table 81. Fujifilm Drug Repositioning Basic Information
Table 82. Fujifilm Drug Repositioning Product Overview
Table 83. Fujifilm Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Fujifilm Business Overview
Table 85. Fujifilm Recent Developments
Table 86. Dr. Reddy Drug Repositioning Basic Information
Table 87. Dr. Reddy Drug Repositioning Product Overview
Table 88. Dr. Reddy Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Dr. Reddy Business Overview
Table 90. Dr. Reddy Recent Developments
Table 91. R-Pharma Drug Repositioning Basic Information
Table 92. R-Pharma Drug Repositioning Product Overview
Table 93. R-Pharma Drug Repositioning Revenue (M USD) and Gross Margin (2019-2024)
Table 94. R-Pharma Business Overview
Table 95. R-Pharma Recent Developments
Table 96. Global Drug Repositioning Market Size Forecast by Region (2025-2030) & (M USD)
Table 97. North America Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Europe Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 99. Asia Pacific Drug Repositioning Market Size Forecast by Region (2025-2030) & (M USD)
Table 100. South America Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Drug Repositioning Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Global Drug Repositioning Market Size Forecast by Type (2025-2030) & (M USD)
Table 103. Global Drug Repositioning Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Drug Repositioning
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repositioning Market Size (M USD), 2019-2030
Figure 5. Global Drug Repositioning Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Repositioning Market Size by Country (M USD)
Figure 10. Global Drug Repositioning Revenue Share by Company in 2023
Figure 11. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Repositioning Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Repositioning Market Share by Type
Figure 15. Market Size Share of Drug Repositioning by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Repositioning by Type in 2022
Figure 17. Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Repositioning Market Share by Application
Figure 20. Global Drug Repositioning Market Share by Application (2019-2024)
Figure 21. Global Drug Repositioning Market Share by Application in 2022
Figure 22. Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Repositioning Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Repositioning Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Repositioning Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Repositioning Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Repositioning Market Size Market Share by Country in 2023
Figure 31. Germany Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Repositioning Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Repositioning Market Size Market Share by Region in 2023
Figure 38. China Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Repositioning Market Size and Growth Rate (M USD)
Figure 44. South America Drug Repositioning Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Repositioning Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Repositioning Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Repositioning Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Repositioning Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Repositioning Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Drug Repositioning
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repositioning Market Size (M USD), 2019-2030
Figure 5. Global Drug Repositioning Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Repositioning Market Size by Country (M USD)
Figure 10. Global Drug Repositioning Revenue Share by Company in 2023
Figure 11. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Repositioning Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Repositioning Market Share by Type
Figure 15. Market Size Share of Drug Repositioning by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Repositioning by Type in 2022
Figure 17. Global Drug Repositioning Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Repositioning Market Share by Application
Figure 20. Global Drug Repositioning Market Share by Application (2019-2024)
Figure 21. Global Drug Repositioning Market Share by Application in 2022
Figure 22. Global Drug Repositioning Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Repositioning Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Repositioning Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Repositioning Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Repositioning Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Repositioning Market Size Market Share by Country in 2023
Figure 31. Germany Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Repositioning Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Repositioning Market Size Market Share by Region in 2023
Figure 38. China Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Repositioning Market Size and Growth Rate (M USD)
Figure 44. South America Drug Repositioning Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Repositioning Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Repositioning Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Repositioning Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Repositioning Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Repositioning Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Repositioning Market Share Forecast by Application (2025-2030)
